Kevin Mclaughlin - Feb 12, 2025 Form 4 Insider Report for Vericel Corp (VCEL)

Role
Director
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin
Stock symbol
VCEL
Transactions as of
Feb 12, 2025
Transactions value $
-$363,050
Form type
4
Date filed
2/14/2025, 04:05 PM
Previous filing
Nov 15, 2024
Next filing
May 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCEL Common Stock Options Exercise $22.4K +6K +50.42% $3.74 17.9K Feb 12, 2025 Direct
transaction VCEL Common Stock Sale -$333K -6K -33.52% $55.47 11.9K Feb 12, 2025 Direct F1
transaction VCEL Common Stock Options Exercise $2.76K +1K +8.4% $2.76 12.9K Feb 12, 2025 Direct
transaction VCEL Common Stock Sale -$55.4K -1K -7.75% $55.43 11.9K Feb 12, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCEL Stock Option (Right to Buy) Options Exercise $0 +6K $0.00 0 Feb 12, 2025 Common Stock 6K $3.74 Direct F2, F3
transaction VCEL Stock Option (Right to Buy) Options Exercise $0 +1K +7.69% $0.00 14K Feb 12, 2025 Common Stock 1K $2.76 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
F2 These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.
F3 These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025
F4 These options, representing the right to purchase a total of 15,000 shares, were originally granted on May 4, 2016, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.